5 not yet recruiting, 5 recruiting, 1 active not recruiting, 1 completed. 3 Phase 4, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Recruiting 2, Not yet recruiting 1 |
| Not applicable | 2 | Active not recruiting 1, Not yet recruiting 1 |
Follow Psoriasis Arthritis: new trials by email Literature Review of Psoriasis Arthritis trials Research Report on Psoriasis Arthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Definition of Novel Optoacoustic Biomarkers of Psoriasis and Psoriatic Arthritis Raster-Scan Optoacoustic Mesoscopy, Multispectral Optoacoustic Tomography, Skin Biopsy and Skin Sample Collection - Psoriasis (PsO), Psoriasis Arthritis | Not applicable | Not yet recruiting | University of Erlangen-Nürnberg Medical School | 192 | 2026-10-07 | 2026-10-21 |
| A Study of Clinical and Immune Responses to Sequential Biologic Therapies in Psoriatic Arthritis Biologic or targeted synthetic DMARD (b/tsDMARD) - Psoriasis Arthritis | Not yet recruiting | Royal United Hospitals Bath NHS Foundation Trust | 400 | 2026-06-01 | 2026-05-13 | |
| Psoriasis Comorbidities at Hospital Calderón Guardia Psoriasis, Psoriasis Arthritis | Not yet recruiting | Caja Costarricense de Seguro Social | 350 | 2026-05-01 | 2026-04-08 | |
| Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease Guselkumab (GUS), Risankizumab (RISA) - Psoriasis, Psoriasis Arthritis | Not yet recruiting | Caja Costarricense de Seguro Social | 50 | 2026-05-01 | 2026-03-09 | |
| GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis Semaglutide 0.5 mg, Semaglutide 1.0 mg, Semaglutide 0.25 mg - Psoriasis Arthritis | Phase 4 | Not yet recruiting | Chinese University of Hong Kong | 40 | 2025-12-01 | 2025-12-02 |
| A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers Prescreen platform, biologics treatment - Psoriasis, Psoriasis Arthritis | Phase 4 | Recruiting | Taichung Veterans General Hospital | 50 | 2025-07-29 | 2025-09-02 |
| A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS) IL-17i - Psoriasis (PsO), Enthesitis | Recruiting | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 50 | 2025-05-01 | 2025-05-23 | |
| Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast) Fasting and Plant-Based Diet - Psoriasis Arthritis, Psoriasis (PsO) | Not applicable | Active not recruiting | Charite University, Berlin, Germany | 30 | 2025-04-04 | 2026-06-08 |
| Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study. Guselkumab - Psoriasis Arthritis | Phase 4 | Recruiting | Fondazione Policlinico Universitario Campus Bio-Medico | 26 | 2024-06-18 | 2025-05-16 |
| Typological Study of Sleep Pathologies During Psoriatic Rheumatism and SAPHO Syndrome: Prospective Study Within the Paris Saint-Joseph Hospital Group" Psoriasis Arthritis, SAPHO Syndrome | Recruiting | Fondation Hôpital Saint-Joseph | 100 | 2023-11-13 | 2025-07-25 | |
| Molecular Inflammation Board at the Center for Personalized Medicine Biologic Agent - Psoriasis (PsO), Psoriasis Arthritis | Recruiting | University Hospital Tuebingen | 3000 | 2022-11-16 | 2025-08-20 | |
| Prospective Evaluation of the Radiographic Efficacy of Enbrel Etanercept - Rheumatoid Arthritis, Psoriasis Arthritis | Completed | Pfizer | 1821 | 2012-02-01 | 2019-08-16 |
Psoriasis (7) · Acquired Hyperostosis Syndrome (1) · Arthritis, Psoriatic (1) · Arthritis, Rheumatoid (1) · Colitis, Ulcerative (1) · Fasting (1) · Inflammatory Bowel Diseases (1) · Sleep Apnea Syndromes (1) · Spondylarthropathies (1)
Skin and Connective Tissue Diseases (8) · Skin Diseases (7) · Skin Diseases, Papulosquamous (7) · Musculoskeletal Diseases (4) · Arthritis (3) · Bone Diseases (3) · Joint Diseases (3) · Spinal Diseases (2) · Spondylarthritis (2) · Spondylitis (2) · Apnea (1) · Autoimmune Diseases (1) · Behavior (1) · Bone Diseases, Developmental (1) · Colitis (1)
guselkumab (2) · Biological Factors (1) · Biological Products (1) · Diet, Plant-Based (1) · Etanercept (1) · risankizumab (1) · semaglutide (1)
Caja Costarricense de Seguro Social (2) · Charite University, Berlin, Germany (1) · Chinese University of Hong Kong (1) · Fondation Hôpital Saint-Joseph (1) · Fondazione Policlinico Universitario Campus Bio-Medico (1) · Pfizer (1) · Royal United Hospitals Bath NHS Foundation Trust (1) · Taichung Veterans General Hospital (1) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1) · University Hospital Tuebingen (1) · University of Erlangen-Nürnberg Medical School (1)
Costa Rica (2) · Germany (2) · China (1) · France (1) · Italy (1) · Taiwan (1) · United Kingdom (1)
James Kimpton, BA (Hons) BM BCh (oxon) MRCP (1)
PMID 12228161, PMID 18259687, PMID 35513599, PMID 36251174, PMID 38243715, PMID 39055795, PMID 41206077